Alexander J. Lazar

Medicine · Health Sciences

150h-index142.1kcitations1.5kworks2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Sarcoma Diagnosis and Treatment(445), Cancer Genomics and Diagnostics(183), Melanoma and MAPK Pathways(140), Cancer Immunotherapy and Biomarkers(133), Vascular Tumors and Angiosarcomas(99)

Publications1.4k total

Classification of non-TCGA cancer samples to TCGA molecular subtypes using compact feature sets
UNC Libraries·2025Open Access
Supplementary Figures 1-2 from Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals <i>TP53</i> Mutation to Be Associated with Worse Outcomes
2025Open Access
Supplementary Tables 1-2 from Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals <i>TP53</i> Mutation to Be Associated with Worse Outcomes
2025Open Access
Abstract PR009: Bugs in Space: Spatial Analysis of the Immune-Microbial Axis in Rectal Cancer Reveals a Unique Interface in Young Onset Rectal Cancers
Clinical Cancer Research·2025
Abstract PR013: Distinct Oral Bacterial Signatures in Rectal Cancer Tumors Associated with Age of Onset and Treatment Response
Clinical Cancer Research·2025
Primary Synovial Sarcoma of the Abdomen and Pelvis
American Journal of Clinical Oncology·2025
Editor’s Note: Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade
Cancer Discovery·2025Open Access
Integrative spatial multi-omics reveal niche-specific inflammatory signaling and differentiation hierarchies in AML
iScience·2025Open Access
Supplementary Figures S1-S5 from Microparticle-Delivered Cxcl9 Prolongs Braf Inhibitor Efficacy in Melanoma
2025Open Access
ATRX Loss Predicts Poor Outcomes and Reveals a Therapeutic Vulnerability to TEAD Inhibition in Soft Tissue Sarcomas
bioRxiv (Cold Spring Harbor Laboratory)·2025Open Access
Supplementary Figures S6-S10 from Microparticle-Delivered Cxcl9 Prolongs Braf Inhibitor Efficacy in Melanoma
2025Open Access
Supplementary Tables from Microparticle-Delivered Cxcl9 Prolongs Braf Inhibitor Efficacy in Melanoma
2025Open Access
Supplementary Figure S2 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
2025Open Access
Supplementary Tables 1 and 6-8 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
2025Open Access
Supplementary Table S3 from Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
2025Open Access
Supplementary Figure S6 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
2025Open Access
Supplementary Table S1 from Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101)
2025Open Access
Supplementary Table 5 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
2025Open Access
Supplementary Figure S8 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
2025Open Access
Supplementary Table S1 from Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
2025Open Access
page 1 of 72Next →

Frequent Co-authors

Vésteinn Thórsson(20), Gad Getz(20), Yuexin Liu(19), Sheila M. Reynolds(19), Ilya Shmulevich(19), Ina Felau(19), Jean C. Zenklusen(19), Michael S. Lawrence(19), Varsha Dhankani(18), John A. Demchok(18), Carolyn M. Hutter(18), Rory Johnson(17), Martin L. Ferguson(17), Roy Tarnuzzer(17), Sudha Chudamani(17), Juok Cho(17), Timothy Defreitas(17), Scott Frazer(17), Nils Gehlenborg(17), David I. Heiman(17)